Tag: investors

NEWTON, Mass., July 10, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer’s disease (AD), will present new findings at the upcoming Alzheimer's Association International Conference (AAIC®) 2025 in Toronto. The presentations include a cost savings analysis of the use of pTau217 as a screening tool in Acumen’s Phase 2 ALTITUDE-AD trial of sabirnetug as well as a nonclinical study evaluating the relative selectivity of sabirnetug to targeting AβOs versus Aβ monomers. The conference will be held July 27-31, 2025, both in-person and online.

IRVINE, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- Sabal Investment Holdings (“Sabal” or “SIH”) today announced the final closings of two private commercial real estate funds: Sabal Strategic Opportunities Fund II and SIH Debt Opportunities Fund III, with total capital commitments of $720 million.

This groundbreaking permit supports the Republic of Maldives climate targets in the global energy transition

 - Regina Hodits, Managing Director to join NUCLIDIUM’s Board of Directors

LONDON, July 10, 2025 (GLOBE NEWSWIRE) -- ATFX Connect participated in the Duke of Edinburgh Cup City of London Qualifying Event, reaffirming our ongoing commitment to purpose-led partnerships and community-focused initiatives. As the Official Partner of the Duke of Edinburgh Cup, ATFX Connect continues to support this long-standing initiative, now in its eighth year, as part of our broader mission to give back through sport, education, and opportunity.

Aalst, Belgium, July 10, 2025 – Ontex Group NV [EURONEXT: ONTEX], a leading international developer and producer of personal care solutions, is proud to have been recognized by CDP* for the second time in a row for its climate actions in partnership with its suppliers, specifically aimed at reducing its scope 3 emissions. Ontex is among the highest-rated companies that are celebrated in the 2024 Supplier Engagement Leaderboard, which evaluates corporate supply chain engagement on climate issues. 

London, UK, July 10, 2025 (GLOBE NEWSWIRE) -- In an era where crypto asset volatility challenges even seasoned traders, one company is standing out with transparent regulation, robust quantitative strategies, and real investor success stories: AB Quantitative Trading (www.abquant.net).

CAMBRIDGE, United Kingdom and MONTREAL, July 10, 2025 (GLOBE NEWSWIRE) -- Epitopea, a transatlantic cancer immunotherapeutics company developing accessible, off-the-shelf RNA-based immunotherapies, today announced the formation of its dedicated clinical team and the expansion of its research team. These developments represent a significant milestone in the company’s ongoing progress in advancing its RNA-based immunotherapies, known as CryptiVax™, into clinical trials.